Key facts
- PYM’s last known valuation is $33.0M (Oct 2024).
- It has raised $10.5M; the latest was Later Stage VC in Feb 2026.
- Notable investors include Gaingels, Calm Ventures, Makai VC, City Light Capital, Cleo Capital — 21 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 21 names
- ·Watchlist + deal alerts for PYM
- ·The full record, as it builds
Funding rounds
No funding rounds for PYM are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About PYM
Producer of all-natural, amino acid-based chewable gums intended to improve neurotransmitter health. The company's chewable gums are made with adaptogens that target the body's hormone levels and contain natural, non-addictive, and non-psychoactive compounds, enabling consumers to manage feelings of stress, anxiety, and overwhelm.
- Sector
- Consumer Products and Services (B2C)
- HQ
- Rancho Mission Viejo, CA, United States
- Founded
- 2019
- Website
- youcanpym.com/
- Ownership
- Privately Held (backing)
PYM doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in PYM shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on PYM in its N-PORT filings yet. We sweep new filings monthly.